Patent · US Active

Macrocyclic lactone compounds and methods for their use

US8088789B2 · kind B2 · utility

20Cited by

16References

28Claims

0Family size

Assignee

Elixir Medical Corporation · US

Inventors

John Yan · Los Gatos, US
Xiaoxia Zheng · Milpitas, US
Vinayak Bhat · Cupertino, US

Key dates

Filing date	Mar 11, 2008
Grant date	Jan 3, 2012
Priority date	—
Expiry date	Sep 17, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating an ophthalmic condition or disease by administering a compound disclosed herein is provided. The compound can be administered systemically or locally and in a variety of ways, such as via a temporary device, an implant, an injection or an eye drop. The compound can also be administered with an additional therapeutic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.